Ahead of opioid trial, Johnson & Johnson settles with Ohio counties for $20 million
Johnson & Johnson has reached a $20.4 million settlement with two counties in Ohio, in order to avoid being part of a major opioid trial slated to start in Cleveland later this month.
Under the terms of the settlement, Cuyahoga and Summit counties will receive $10 million in cash, $5 million as reimbursement for legal fees, and $5.4 million for opioid-related nonprofits. The deal does not include an admission of liability. In a statement Tuesday night, Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, said the company "recognizes the opioid crisis is a complex public health challenge and is working collaboratively to help communities and people in need."
Later this month, six companies — including Walgreens and Teva Pharmaceuticals — are scheduled to be defendants in a federal trial, accused of being responsible for the opioid epidemic that has left more than 20,000 people dead in the United States over the last 20 years. In August, Johnson & Johnson, which owns two companies that process and import the material used to manufacture oxycodone, was ordered to pay $572 million for its role in Oklahoma's opioid epidemic. The company has denied any wrongdoing and has appealed.
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
